A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Conditions
Recurrent or Metastatic Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Los Angeles Cancer Network, Los Angeles, California, United States
Contact: Study coordinator (Principal Investigator)Valkyrie Clinical Trials, Los Angeles, California, United States
Pih Health Hematology Medical Oncology, Whittier, California, United States
Contact: Study coordinator (Principal Investigator)Orchard Healthcare Research Inc., Skokie, Illinois, United States
Contact: Study coordinator (Principal Investigator)M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States
Contact: Study coordinator (Principal Investigator)NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Principal Investigator)Icahn School of Medicine At Mount Sinai Prime, New York, New York, United States
Contact: Study coordinator (Principal Investigator)Clinical Research Alliance, Westbury, New York, United States
Contact: Study coordinator (Principal Investigator)Tn Gynecologic Oncology Group, Llc, Chattanooga, Tennessee, United States
Contact: Study coordinator (Principal Investigator)The West Clinic, Germantown, Tennessee, United States
Contact: Study coordinator (Principal Investigator)SCRI Oncology Partners, Nashville, Tennessee, United States
Texas Oncology - West Texas, Amarillo, Texas, United States
Texas Oncology, P.A., Dallas, Texas, United States
Texas Oncology Gulf Coast, Pearland, Texas, United States
University of Utah Hospitals & Clinics, Salt Lake City, Utah, United States
Contact: Study coordinator (Principal Investigator)Virginia Cancer Specialists, Fairfax, Virginia, United States
Wenatchee Hospitals and Clinics, Wenatchee, Washington, United States
Contact: Study coordinator (Principal Investigator)DIABAID, Buenos Aires, Argentina
Contact: Study coordinator (Principal Investigator)Hospital Aleman, Buenos Aires, Argentina
Contact: Study coordinator (Principal Investigator)Hospital Sirio Libanes, Caba, Argentina
Contact: Study coordinator (Principal Investigator)Centro Médico Austral, Ciudad Autonoma Buenos Aires, Argentina
Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata, Argentina
Contact: Study coordinator (Principal Investigator)Genesiscare North Shore Oncology, St Leonards, New South Wales, Australia
Contact: Study coordinator (Principal Investigator)Blacktown Hospital, Blacktown, Australia
St Vincent'S Hospital Sydney, Mount Kuring-Gai, Australia
Contact: Study coordinator (Principal Investigator)St John of God Subiaco Hospital, Subiaco, Australia
Contact: Study coordinator (Principal Investigator)Princess Alexandra Hospital, Woolloongabba, Australia
Contact: Study coordinator (Principal Investigator)Cliniques Universitaires Saint-Luc, Brussels, Belgium
Contact: Study coordinator (Principal Investigator)Grand Hospital de Charleroi, Charleroi, Belgium
Contact: Study coordinator (Principal Investigator)Universitair Ziekenhuis Gent, Ghent, Belgium
Contact: Study coordinator (Principal Investigator)Uz Leuven, Leuven, Belgium
Contact: Study coordinator (Principal Investigator)Chu de Liă Ge, Liège, Belgium
Contact: Study coordinator (Principal Investigator)Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, Brazil
Contact: Study coordinator (Principal Investigator)Cepon - Centro de Pesquisas Oncolă"Gicas de Santa Catarina, Florianópolis, Brazil
Contact: Study coordinator (Principal Investigator)Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho, Jaú, Brazil
Contact: Study coordinator (Principal Investigator)Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Contact: Study coordinator (Principal Investigator)Hospital São Lucas Da Pucrs, Porto Alegre, Brazil
Contact: Study coordinator (Principal Investigator)Biocenter, Concepción, Chile
Contact: Study coordinator (Principal Investigator)Ic La Serena Research, La Serena, Chile
Contact: Study coordinator (Principal Investigator)Centro Del Cancer UC, Santiago, Chile
Contact: Study coordinator (Principal Investigator)Clinica Redsalud Vitacura, Santiago, Chile
Contact: Study coordinator (Principal Investigator)James Lind Centro de Investigacion Del Cancer, Temuco, Chile
Contact: Study coordinator (Principal Investigator)Centre Léon Bérard, Lyon, Rhone, France
Contact: Study coordinator (Principal Investigator)Chu Besançon - Hôpital Jean Minjoz, Besançon, France
Contact: Study coordinator (Principal Investigator)Hopital Saint Andre, Bordeaux, France
Institut Bergonié, Bordeaux, France
Centre Georges François Leclerc, Dijon, France
Contact: Study coordinator (Principal Investigator)Institut Régional Du Cancer de Montpellier, Montpellier, France
Contact: Study coordinator (Principal Investigator)Institut Curie - Site de Paris, Paris, France
Contact: Study coordinator (Principal Investigator)CRLCC Eugene Marquis, Rennes, France
Ico - Site René Gauducheau, Saint-Herblain, France
Contact: Study coordinator (Principal Investigator)Institut Claudius Regaud, Toulouse, France
Contact: Study coordinator (Principal Investigator)Institut Gustave Roussy, Villejuif, France
Contact: Study coordinator (Principal Investigator)Charită - Campus Charită Mitte, Berlin, Germany
Contact: Study coordinator (Principal Investigator)Vivantes Klinikum Neukoelln, Berlin, Germany
Contact: Study coordinator (Principal Investigator)Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt, Dresden, Germany
Contact: Study coordinator (Principal Investigator)Universitaetsklinikum Heidelberg, Heidelberg, Germany
Contact: Study coordinator (Principal Investigator)Slk-Kliniken Heilbronn Gmbh, Heilbronn, Germany
Contact: Study coordinator (Principal Investigator)Universitäres Krebszentrum Leipzig UCCL, UKL AöR, Leipzig, Germany
Contact: Study coordinator (Principal Investigator)Univ der Johannes GutenbergU, Mainz, Germany
Contact: Study coordinator (Principal Investigator)Universitätsklinikum Münster, Medizinische Klinik A, Münster, Germany
Contact: Study coordinator (Principal Investigator)Cork University Hospital, Cork, Ireland
Contact: Study coordinator (Principal Investigator)Mater Misericordiae University Hospital, Dublin, Ireland
Contact: Study coordinator (Principal Investigator)Tallaght University Hospital, Dublin, Ireland
Contact: Study coordinator (Principal Investigator)St Vincent'S University Hospital, Dublin, Ireland
Contact: Study coordinator (Principal Investigator)University Hospital Galway, Galway, Ireland
Contact: Study coordinator (Principal Investigator)Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo, Candiolo, Italy
Contact: Study coordinator (Principal Investigator)Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Contact: Study coordinator (Principal Investigator)Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milan, Italy
Contact: Study coordinator (Principal Investigator)Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy
Contact: Study coordinator (Principal Investigator)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Contact: Study coordinator (Principal Investigator)Istituto Clinico Humanitas, Rozzano, Italy
Contact: Study coordinator (Principal Investigator)National Cancer Center Hospital, Chūōku, Japan
Contact: Study coordinator (Principal Investigator)National Cancer Center Hospital East, Kashiwa, Japan
Contact: Study coordinator (Principal Investigator)The Cancer Institute Hospital of Jfcr, Kōtoku, Japan
Contact: Study coordinator (Principal Investigator)National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
Contact: Study coordinator (Principal Investigator)Shizuoka Cancer Center, Nagaizumi-cho, Japan
Contact: Study coordinator (Principal Investigator)Aichi Cancer Center Hospital, Nagoya, Japan
Contact: Study coordinator (Principal Investigator)Kindai University Hospital, Ōsaka-sayama, Japan
Contact: Study coordinator (Principal Investigator)Saitama Cancer Center, Saitama, Japan
Contact: Study coordinator (Principal Investigator)Medical Care & Research Sa de Cv, Mérida, Mexico
Contact: Study coordinator (Principal Investigator)Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida, Mexico
Contact: Study coordinator (Principal Investigator)Cryptex Investigacion Clinica S.A. de C.V., México, Mexico
Contact: Study coordinator (Principal Investigator)Amsterdam Umc, Locatie Vumc, Amsterdam, Netherlands
Contact: Study coordinator (Principal Investigator)Universitair Medisch Centrum Groningen, Groningen, Netherlands
Radboudumc Nijmegen, Nijmegen, Netherlands
Contact: Study coordinator (Principal Investigator)Erasmus Medisch Centrum, Rotterdam, Netherlands
Contact: Study coordinator (Principal Investigator)Erasmus Medisch Centrum, Rotterdam, Netherlands
Contact: Study coordinator (Principal Investigator)Umc Utrecht, Utrecht, Netherlands
Contact: Study coordinator (Principal Investigator)SPZOZ Szpital Uniwer w Krakowie, Krakow, Poland
Instytut MSF Sp. z o.o., Lodz, Poland
MRUK-MED i Spółka z ograniczoną odpowiedzialnością, Rzeszów, Poland
Contact: Study coordinator (Principal Investigator)Mazowiecki Szpital Wojewodzki W Siedlcach Sp Z O O, Siedlce, Poland
Contact: Study coordinator (Principal Investigator)Aidport Sp Z O.O., Skorzewo, Poland
Contact: Study coordinator (Principal Investigator)Instituto Portuguă S de Oncologia de Lisboa Francisco Gentil, Epe, Lisbon, Portugal
Contact: Study coordinator (Principal Investigator)Fundação Champalimaud, Lisbon, Portugal
Contact: Study coordinator (Principal Investigator)Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal
Contact: Study coordinator (Principal Investigator)Centro Hospitalar Universitario de Santo Antonio, Porto, Portugal
Contact: Study coordinator (Principal Investigator)Inst Portude Onco do Porto, Porto, Portugal
Contact: Study coordinator (Principal Investigator)Hospital Clinic de Barcelona, Barcelona, Spain
Contact: Study coordinator (Principal Investigator)ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain
Hospital Universitari Vall D'Hebron, Barcelona, Spain
Contact: Study coordinator (Principal Investigator)Hospital General Universitario Gregorio Marañon, Madrid, Spain
Contact: Study coordinator (Principal Investigator)Hospital Clínico San Carlos, Madrid, Spain
Contact: Study coordinator (Principal Investigator)Hospital Universitario 12 de Octubre, Madrid, Spain
Contact: Study coordinator (Principal Investigator)Hospital Universitario La Paz, Madrid, Spain
Contact: Study coordinator (Principal Investigator)Hospital Universitario Virgen Macarena, Seville, Spain
Contact: Study coordinator (Principal Investigator)China Medical University Hospital, Taichung, Taiwan
Contact: Study coordinator (Principal Investigator)National Cheng Kung University Hospitalx, Tainan, Taiwan
Contact: Study coordinator (Principal Investigator)National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Principal Investigator)Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Study coordinator (Principal Investigator)Koo Foundation Sun Yat-Sen cancer center, Taipei, Taiwan
Tri-Service General Hospital, Taipei, Taiwan
Contact: Study coordinator (Principal Investigator)Gulhane Training and Research Hospital, Ankara, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)Gazi University Medical Faculty, Ankara, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)Ankara University Cebeci Hospital, Ankara, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)Ankara City Hospital, Ankara, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)Medipol Mega University Hospital, Istanbul, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)Izmir Medicalpark Hospital, Izmir, Turkey (Türkiye)
Contact: Study coordinator (Principal Investigator)